148 related articles for article (PubMed ID: 37846505)
1. Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana.
Otabil KB; Basáñez MG; Ankrah B; Opoku SA; Kyei DO; Hagan R; Ababio R; Bart-Plange EJ; Babae TN; Kudzordzi PC; Darko VA; Bamfo JG; Ameyaw J; Raji AS; Hadermann A; Schallig HDFH; Colebunders R
Trop Med Int Health; 2023 Nov; 28(11):844-854. PubMed ID: 37846505
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin.
Otabil KB; Ankrah B; Bart-Plange EJ; Donkoh ES; Avarikame FA; Ofori-Appiah FO; Babae TN; Kudzordzi PC; Darko VA; Ameyaw J; Bamfo JG; Sakibu RA; Antwi-Berko D; Fodjo JNS; Basáñez MG; Schallig HDFH; Colebunders R
Infect Dis Poverty; 2023 Aug; 12(1):75. PubMed ID: 37587500
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
Otabil KB; Gyasi SF; Awuah E; Obeng-Ofori D; Atta-Nyarko RJ; Andoh D; Conduah B; Agbenyikey L; Aseidu P; Ankrah CB; Nuhu AR; Schallig HDFH
BMC Infect Dis; 2019 May; 19(1):431. PubMed ID: 31101085
[TBL] [Abstract][Full Text] [Related]
4. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.
Murdoch ME; Asuzu MC; Hagan M; Makunde WH; Ngoumou P; Ogbuagu KF; Okello D; Ozoh G; Remme J
Ann Trop Med Parasitol; 2002 Apr; 96(3):283-96. PubMed ID: 12061975
[TBL] [Abstract][Full Text] [Related]
5. Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
Djune-Yemeli L; Domché A; Nana-Djeunga HC; Donfo-Azafack C; Lenou-Nanga CG; Masumbe-Netongo P; Kamgno J
PLoS Negl Trop Dis; 2022 May; 16(5):e0010380. PubMed ID: 35499993
[TBL] [Abstract][Full Text] [Related]
6. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
Brieger WR; Awedoba AK; Eneanya CI; Hagan M; Ogbuagu KF; Okello DO; Ososanya OO; Ovuga EB; Noma M; Kale OO; Burnham GM; Remme JH
Trop Med Int Health; 1998 Dec; 3(12):951-61. PubMed ID: 9892280
[TBL] [Abstract][Full Text] [Related]
7. Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
Osue HO
Ethiop J Health Sci; 2017 Mar; 27(2):129-138. PubMed ID: 28579708
[TBL] [Abstract][Full Text] [Related]
8. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
[TBL] [Abstract][Full Text] [Related]
9. Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
BMC Public Health; 2020 Aug; 20(1):1233. PubMed ID: 32787813
[TBL] [Abstract][Full Text] [Related]
10. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
[TBL] [Abstract][Full Text] [Related]
11. Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study.
Otabil KB; Basáñez MG; Ankrah B; Bart-Plange EJ; Babae TN; Kudzordzi PC; Darko VA; Raji AS; Datsa L; Boakye AA; Yeboah MT; Fodjo JNS; Schallig HDFH; Colebunders R
BMC Infect Dis; 2023 Nov; 23(1):805. PubMed ID: 37974087
[TBL] [Abstract][Full Text] [Related]
12. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
Evans DS; Alphonsus K; Umaru J; Eigege A; Miri E; Mafuyai H; Gonzales-Peralta C; Adamani W; Pede E; Umbugadu C; Saka Y; Okoeguale B; Richards FO
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3113. PubMed ID: 25233351
[TBL] [Abstract][Full Text] [Related]
13. Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment.
Mweya CN; Kalinga AK; Kabula B; Malley KD; Ruhiso MH; Maegga BT
Tanzan Health Res Bull; 2007 Sep; 9(3):174-9. PubMed ID: 18087895
[TBL] [Abstract][Full Text] [Related]
14. Dermatological problems of onchocerciasis in Nebbi District, Uganda.
Okello DO; Ovuga EB; Ogwal-Okeng JW
East Afr Med J; 1995 May; 72(5):295-8. PubMed ID: 7555885
[TBL] [Abstract][Full Text] [Related]
15. Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.
Bottomley C; Isham V; Vivas-Martínez S; Kuesel AC; Attah SK; Opoku NO; Lustigman S; Walker M; Basáñez MG
Parasit Vectors; 2016 Jun; 9(1):343. PubMed ID: 27301567
[TBL] [Abstract][Full Text] [Related]
16. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Koudou B; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y; Bockarie MJ
Infect Dis Poverty; 2018 Apr; 7(1):30. PubMed ID: 29628019
[TBL] [Abstract][Full Text] [Related]
17. Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.
Murdoch ME; Murdoch IE; Evans J; Yahaya H; Njepuome N; Cousens S; Jones BR; Abiose A
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005489. PubMed ID: 28355223
[TBL] [Abstract][Full Text] [Related]
18. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
19. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.
Golden A; Faulx D; Kalnoky M; Stevens E; Yokobe L; Peck R; Karabou P; Banla M; Rao R; Adade K; Gantin RG; Komlan K; Soboslay PT; de Los Santos T; Domingo GJ
Parasit Vectors; 2016 Jun; 9(1):338. PubMed ID: 27296630
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
